In order to analyze the potential of IFN-CAR T-cells to act as a short-term neo-adjuvant therapy intended to reduce tumor size for subsequent surgical removal, we propose an orthotopic model of pancreas carcinoma. This evidence concerns the gene IFNA1 and neoplasm.